Wikipedia:Articles for deletion/Birtamimab


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete.  Sandstein  19:32, 1 October 2018 (UTC)

Birtamimab

 * – ( View AfD View log  Stats )

too early for an article. except a name (tho the structural formula is in the reference) No information provided about state of any therapeutic trials. No information about why it might be "designed for the treatment of amyloidosis" I question whether it is appropriate to have an article until there is some actual published information.

Nominated separately in case one of this group of articles might show notability DGG ( talk ) 06:43, 24 September 2018 (UTC)  DGG ( talk ) 06:44, 24 September 2018 (UTC)
 * Delete in presumed absence of inofficial practices to keep these phantoms. Name registered + in development seems a mite too early to have an article. -- Elmidae (talk · contribs) 16:03, 25 September 2018 (UTC)
 * Merge with Amyloidosis, since it is related to that. Leo1pard (talk) 16:57, 25 September 2018 (UTC)
 * Delete Development has been halted, so it is unlikely that more information will become available. Natureium (talk) 17:50, 25 September 2018 (UTC)
 * Comment a merge is inappropriate--we do not merge al lpossible not yet approved medicines to a medical condition.  DGG ( talk ) 08:54, 29 September 2018 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.